Article (Scientific journals)
Prognostic factors in patients with Zollinger-Ellison syndrome and multiple endocrine neoplasia type 1. Groupe d'Etude des Neoplasies Endocriniennes Multiples (GENEM and groupe de Recherche et d'Etude du Syndrome de Zollinger-Ellison (GRESZE).
Cadiot, G.; Vuagnat, A.; Doukhan, I. et al.
1999In Gastroenterology, 116 (2), p. 286-293
Peer Reviewed verified by ORBi
 

Files


Full Text
Prognostic factors in patients with Zollinger-Ellison syndrome and multiple endocrine neoplasia type 1.pdf
Publisher postprint (127.83 kB)
Request a copy

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
Adult; Aged; Female; Humans; Liver Neoplasms/secondary; Male; Medical Records; Middle Aged; Multiple Endocrine Neoplasia Type 1/diagnosis; Multivariate Analysis; Neoplasms, Second Primary/diagnosis; Odds Ratio; Pancreatic Neoplasms/pathology; Predictive Value of Tests; Prognosis; Retrospective Studies; Risk Factors; Survival Analysis; Zollinger-Ellison Syndrome/diagnosis
Abstract :
[en] BACKGROUND & AIMS: Risk factors of metachronous liver metastases and death are not well known in patients with the Zollinger-Ellison syndrome and multiple endocrine neoplasia type 1. These factors were retrospectively determined in 77 patients. METHODS: Data chart review was performed. RESULTS: Median follow-up was 102 months (range, 12-366). Surgery was performed on 48 patients, including 9 of the 10 patients with large pancreatic tumors (>/=3 cm). Liver metastases developed in 4 patients (40%) with large pancreatic tumors, in 3 (4.8%) without, and in 1 of the 4 patients with pancreatic tumors of unknown size; all had previously undergone surgery. The only independent factor associated with development of liver metastases identified by multivariate analysis was large pancreatic tumors (risk ratio, 29.0; 95% confidence interval [CI], 3. 2-260.7). Surgery was not selected. The probability of being free of liver metastases in the 63 patients without large pancreatic tumors was 96% (95% CI, 88-100) at 10 and 15 years. Thirteen (16.9%) patients died. The only independent factors of death selected by multivariate analysis were Zollinger-Ellison syndrome diagnosis before 1980 (risk ratio, 8.2; 95% CI, 1.7-40.6) and age at diagnosis (risk ratio/year, 1.08; 95% CI, 1.03-1.14). CONCLUSIONS: Large pancreatic tumors are predictive of the development of metachronous liver metastases, and surgery does not seem to prevent them.
Disciplines :
Endocrinology, metabolism & nutrition
Author, co-author :
Cadiot, G.
Vuagnat, A.
Doukhan, I.
Murat, A.
Bonnaud, G.
Delemer, B.
Thiefin, G.
Beckers, Albert ;  Université de Liège - ULiège > Département des sciences cliniques > Endocrinologie
Veyrac, M.
Proye, C.
Ruszniewski, P.
Mignon, M.
Language :
English
Title :
Prognostic factors in patients with Zollinger-Ellison syndrome and multiple endocrine neoplasia type 1. Groupe d'Etude des Neoplasies Endocriniennes Multiples (GENEM and groupe de Recherche et d'Etude du Syndrome de Zollinger-Ellison (GRESZE).
Publication date :
February 1999
Journal title :
Gastroenterology
ISSN :
0016-5085
eISSN :
1528-0012
Publisher :
W.B. Saunders, Philadelphia, United States - Pennsylvania
Volume :
116
Issue :
2
Pages :
286-293
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 17 May 2010

Statistics


Number of views
83 (1 by ULiège)
Number of downloads
1 (1 by ULiège)

Scopus citations®
 
159
Scopus citations®
without self-citations
127
OpenCitations
 
136

Bibliography


Similar publications



Contact ORBi